Key facts
- Notable investors include Dong-A Chammed.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Hufit
- ·The full record, as it builds
Funding rounds
No funding rounds for Hufit are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hufit
Developer of a diagnostic kit designed for field analysis of infectious diseases. The company specializes in medical and molecular diagnostics point of care and helps to identify various diseases and infections like the coronavirus and more, enabling healthcare professionals to seamlessly diagnose to plan the course of treatment.
- Sector
- Healthcare
- HQ
- Gangwon, South Korea
- Founded
- 2018
- Employees
- 9
- Website
- hufitdia.com/
- Ownership
- Privately Held (backing)
Hufit doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hufit shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hufit in its N-PORT filings yet. We sweep new filings monthly.